CCL2 and hydrops fetalis: CCL2 plays a crucial role in adverse remodeling, fibrosis, and dysfunction in patients with both infarctive and non-infarctive HF [37, 38] and has been proposed as a potential therapeutic target for conditions related to myocardial injury and adverse remodeling [39].